Screening for Chronic Kidney Disease in type 2 diabetic patients: Single centre study

Abstract

iabetes mellitus is the most common cause of chronic kidney disease in the world, leading to multiple complications including end-stage renal disease, cardiovascular disease and even death so, Screening is an important strategy to address the burden of CKD in diabetic population. International clinical guidelines recommend CKD screening for individuals with risk factors such as diabetes, using laboratory assessments of glomerular filtration rate (GFR) and urine albumin excretion. Our study is across sectional study of 200 type 2 diabetic patients who were screened in Alagouza Hospital for CKD by using urinary ACR and average eGFR. Patients with CKD were further investigated for extra renal diabetic complications as PVD and cardiovascular complications by using LL arterial duplex and Echocardiography. Of our 200 type 2 diabetic patients, 55% were males and 45% were females. Duration of diabetes among the studied patients ranged from 2 months to 2years with median of 7 years most of the patients (71.5%) had diabetes for less than 10 years. 49.5% of the studied patients were under treatment with oral antidiabetics, while 44% were treated by Insulin and 6.5% were treated by combined therapy. Hypertension was found in 36% of the studied patients.